Anna Mc Laughlin, Dr. rer.nat.



  • Joined Pharmetheus in 2022, actively working in client projects.
  • Expertise includes pharmacometrics and model-informed precision dosing of cellular therapies, targeted oral drugs, and targeted drug delivery in therapeutic areas such as oncology and immuno-oncology.
  • Pharmacist (2017) and Dr. rer. nat. in Pharmacometrics (2021) from Freie Universitaet Berlin, Germany.
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Model-informed drug development of autologous CAR-T cell therapy: Strategies to optimize CAR-T cell exposure leveraging cell kinetic/dynamic modelingPII-041 – Potential strategies to optimize CAR-T cell exposure in absence of dose-exposure relationships leveraging cell kinetic/dynamic models